Ramachandran Murali

Ramachandran Murali

Chief Tech/Sci/R&D Officer at KAIROS PHARMA, LTD.

Net worth: 152 460 $ as of 2026-05-30

66 year
Health Technology
Consumer Services
Health Services

Profile

Dr. Ramachandran Murali is an Associate Professor at University of Pennsylvania, a Professor at Cedars-Sinai Medical Center and a Vice President-Research & Development at Kairos Pharma Ltd. Dr. Murali was previously employed as a Founder by Soligenix, Inc., a Founder by Ception Therapeutics, Inc., and a Co-Founder by Xcyte Therapeutics.
He received his doctorate degree from the University of Madras.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-10-07 299,529 ( 1.4% ) 152 460 $ 2026-05-30

Ramachandran Murali active positions

CompaniesPositionStart
KAIROS PHARMA, LTD. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Ramachandran Murali

CompaniesPositionEnd
Corporate Officer/Principal -
Founder -
SOLIGENIX, INC. Founder -
See the detail of Ramachandran Murali's experience

Training of Ramachandran Murali

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Ramachandran Murali
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!